63.71
price down icon0.41%   -0.26
after-market Handel nachbörslich: 63.59 -0.12 -0.19%
loading
Schlusskurs vom Vortag:
$63.97
Offen:
$62.2
24-Stunden-Volumen:
295.89K
Relative Volume:
0.47
Marktkapitalisierung:
$3.36B
Einnahmen:
$155.82M
Nettoeinkommen (Verlust:
$-40.42M
KGV:
-89.73
EPS:
-0.71
Netto-Cashflow:
$3.58M
1W Leistung:
+2.72%
1M Leistung:
-11.71%
6M Leistung:
-24.43%
1J Leistung:
+24.00%
1-Tages-Spanne:
Value
$61.00
$64.17
1-Wochen-Bereich:
Value
$60.80
$66.90
52-Wochen-Spanne:
Value
$47.88
$107.37

Arcellx Inc Stock (ACLX) Company Profile

Name
Firmenname
Arcellx Inc
Name
Telefon
240-327-0603
Name
Adresse
800 BRIDGE PARKWAY, REDWOOD CITY
Name
Mitarbeiter
163
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ACLX's Discussions on Twitter

Vergleichen Sie ACLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ACLX
Arcellx Inc
63.71 3.36B 155.82M -40.42M 3.58M -0.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-08 Eingeleitet Redburn Atlantic Buy
2024-09-03 Eingeleitet Cantor Fitzgerald Overweight
2024-05-31 Eingeleitet Piper Sandler Overweight
2024-03-07 Eingeleitet Morgan Stanley Overweight
2024-01-04 Bestätigt Needham Buy
2023-12-19 Eingeleitet Scotiabank Sector Outperform
2023-10-30 Eingeleitet TD Cowen Outperform
2023-10-17 Eingeleitet UBS Buy
2023-05-18 Eingeleitet Truist Buy
2023-04-14 Eingeleitet Robert W. Baird Outperform
2023-03-14 Eingeleitet Stifel Buy
2023-02-13 Eingeleitet H.C. Wainwright Buy
2022-12-13 Fortgesetzt BofA Securities Buy
2022-10-31 Eingeleitet Guggenheim Buy
2022-10-27 Eingeleitet Needham Buy
2022-07-20 Eingeleitet Canaccord Genuity Buy
2022-03-01 Eingeleitet BofA Securities Buy
2022-03-01 Eingeleitet SVB Leerink Outperform
Alle ansehen

Arcellx Inc Aktie (ACLX) Neueste Nachrichten

pulisher
Apr 23, 2025

Arcellx, Inc. (ACLX): Among Takeover Rumors Hedge Funds Are Buying - Yahoo Finance

Apr 23, 2025
pulisher
Apr 15, 2025

Alliancebernstein L.P. Sells 6,181 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

(ACLX) Proactive Strategies - news.stocktradersdaily.com

Apr 14, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Trims Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

Insider Selling: Arcellx, Inc. (NASDAQ:ACLX) Director Sells 1,500 Shares of Stock - MarketBeat

Apr 13, 2025
pulisher
Apr 11, 2025

Arcellx (ACLX): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential - Insider Monkey

Apr 11, 2025
pulisher
Apr 10, 2025

Arcellx (NASDAQ:ACLX) Trading Down 6.8% on Insider Selling - Defense World

Apr 10, 2025
pulisher
Apr 09, 2025

Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

Arcellx director Kavita Patel sells shares worth $86,250 By Investing.com - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

Sei Investments Co. Purchases 4,827 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Arcellx director Kavita Patel sells shares worth $86,250 - Investing.com

Apr 08, 2025
pulisher
Apr 08, 2025

29,446 Shares in Arcellx, Inc. (NASDAQ:ACLX) Purchased by American Century Companies Inc. - Defense World

Apr 08, 2025
pulisher
Apr 05, 2025

Vanguard Group Inc. Grows Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Arcellx, Inc. (NASDAQ:ACLX) Stake Lessened by Corebridge Financial Inc. - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - Benzinga

Apr 02, 2025
pulisher
Apr 02, 2025

What You Didn’t Know About Arcellx Inc (NASDAQ: ACLX) This Week - stocksregister.com

Apr 02, 2025
pulisher
Apr 01, 2025

Arcellx Inc (ACLX) rating initates by Redburn Atlantic - knoxdaily.com

Apr 01, 2025
pulisher
Mar 31, 2025

Teacher Retirement System of Texas Purchases 1,505 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 31, 2025
pulisher
Mar 29, 2025

In 2025, Will Arcellx Inc (NASDAQ: ACLX) Be Bullish Or Bearish? - Stocks Register

Mar 29, 2025
pulisher
Mar 29, 2025

How To Trade (ACLX) - news.stocktradersdaily.com

Mar 29, 2025
pulisher
Mar 25, 2025

Swiss National Bank Buys 500 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 25, 2025
pulisher
Mar 22, 2025

Raymond James Financial Inc. Acquires New Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 22, 2025
pulisher
Mar 20, 2025

Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors - BioSpace

Mar 20, 2025
pulisher
Mar 20, 2025

Arcellx Inc Announces Board Changes for Strategic Growth - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Arcellx names new board members, gears up for 2026 launch By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

Arcellx Appoints Andrew Galligan And Kristin Myers To Its Board Of Directors - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Arcellx names new board members, gears up for 2026 launch - Investing.com

Mar 20, 2025
pulisher
Mar 19, 2025

Arcellx director Kavita Patel sells $107,460 in common stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Arcellx director Kavita Patel sells $107,460 in common stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Arcellx CMO Discusses Novel Investigational CAR-T Therapy During Multiple Myeloma Awareness Month - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Charles Schwab Investment Management Inc. Buys 14,992 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Arcellx Impressive Safety Data Leaves Doubts (NASDAQ:ACLX) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 14, 2025

Bank of New York Mellon Corp Buys 27,350 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Barclays Sticks to Its Buy Rating for Arcellx Inc (ACLX) - The Globe and Mail

Mar 14, 2025
pulisher
Mar 13, 2025

US Bancorp DE Has $462,000 Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

ACLX June 20th Options Begin Trading - Nasdaq

Mar 12, 2025
pulisher
Mar 09, 2025

Arcellx (NASDAQ:ACLX) Shares Gap Up – Time to Buy? - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Principal Financial Group Inc. Trims Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Myesha Lacy - ir-impact.com

Mar 06, 2025
pulisher
Mar 05, 2025

CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain - GlobeNewswire Inc.

Mar 05, 2025
pulisher
Mar 05, 2025

Need To Know: Analysts Just Made A Substantial Cut To Their Arcellx, Inc. (NASDAQ:ACLX) Estimates - Simply Wall St

Mar 05, 2025
pulisher
Mar 03, 2025

We're Not Worried About Arcellx's (NASDAQ:ACLX) Cash Burn - Yahoo Finance

Mar 03, 2025
pulisher
Mar 03, 2025

New York State Common Retirement Fund Has $1.55 Million Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Mar 03, 2025
pulisher
Mar 03, 2025

HC Wainwright Predicts Arcellx’s Q1 Earnings (NASDAQ:ACLX) - Defense World

Mar 03, 2025

Finanzdaten der Arcellx Inc-Aktie (ACLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Arcellx Inc-Aktie (ACLX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Patel Kavita
Director
Apr 08 '25
Sale
57.50
1,500
86,250
0
Patel Kavita
Director
Mar 18 '25
Option Exercise
6.66
1,500
9,990
1,500
Patel Kavita
Director
Mar 18 '25
Sale
71.64
1,500
107,460
0
Elghandour Rami
SEE REMARKS
Feb 07 '25
Option Exercise
0.00
70,211
0
187,486
Elghandour Rami
SEE REMARKS
Feb 26 '25
Sale
62.02
38,300
2,375,517
149,186
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Kapitalisierung:     |  Volumen (24h):